Inward Investment

Inward Investment News

View news from other Pharmaceutical sectors:
31-45 of 421 results
Alliance Pharmaceuticals acquires rights to Novartis' Syntometrine obstetric drug
By PBR Staff Writer
Alliance Pharmaceuticals Limited, a wholly owned subsidiary of Alliance Pharma, has purchased all the existing rights to obstetric drug Syntometrine from Novartis for $11.5m.
Inward Investment > News
Aqua takes over US rights to Verdeso Foam from Stiefel
By PBR Staff Writer
Aqua Pharmaceuticals has added low-potency foam corticosteroid to its dermatology portfolio with the acquisition of US rights and re-launch of Verdeso (desonide) Foam, 0.05% from Stiefel, a GSK company.
Inward Investment > News
Sun Pharma may acquire Sweden’s Meda
By PBR Staff Writer
India-based drugmaker Sun Pharmaceutical Industries is said to be in advanced negotiations to acquire Sweden-based Meda in a deal valued at $5-$6bn.
Inward Investment > News
GlaxoSmithKline acquires Okairos for EUR250m to boost vaccines business
By PBR Staff Writer
GlaxoSmithKline (GSK) has acquired a Switzerland-based vaccines company, Okairos, for €250m in cash to boost its existing vaccine platform technology expertise and to continue developing the next generation of vaccines.
Inward Investment > News
AstraZeneca to take over Omthera Pharmaceuticals
By PBR Staff Writer
AstraZeneca has agreed to acquire Omthera Pharmaceuticals along with novel dyslipidemia treatment in a deal, which has a total potential cost of nearly $443m.
Inward Investment > News
Campus Biotech buys Merck Geneva headquarters
By PBR Staff Writer
The Campus Biotech Consortium has purchased Merck KGaA (MRK)'s Geneva headquarters to create a biotechnology campus.
Inward Investment > News
Bayer to acquire Steigerwald Arzneimittelwerk
By PBR Staff Writer
Bayer has signed an agreement to purchase 100% of the shares of Steigerwald Arzneimittelwerk.
Inward Investment > News
Sagent Pharmaceuticals to acquire remaining stake in KSPC JV
By PBR Staff Writer
Sagent Pharmaceuticals has signed an agreement to acquire 50% interest of its joint venture (JV) partner, Chengdu Kanghong Pharmaceuticals, in the Kanghong Sagent Pharmaceutical (KSPC) JV, for $25m.
Inward Investment > News
ChemRar signs scouting pharma partnering agreement with Sanofi
By PBR Staff Writer
ChemRar Ventures has entered into scouting agreement with Sanofi for a venture investment in Russia and Asia.
Inward Investment > News
Parexel acquires Heron Group
By PBR Staff Writer
Parexel, a US-based clinical research organization, has acquired the equity securities of the Heron Group, a life sciences consultancy which provides evidence-based commercialization services to support biopharmaceutical companies throughout the lifecycle of their products.
Inward Investment > News
Merck funds Canadian life sciences research
By PBR Staff Writer
Merck Canada will provide $4m to the Institute for Research in Immunology and Cancer - Commercialization of Research (IRICoR) for future corridor projects, which are developed in association with two other Canadian Centres of Excellence for Commercialization and Research (CECRs) in Ontario and in British Columbia.
Inward Investment > News
Eli Lilly acquires Siemens investigational PET tracers for Alzheimer's research
By PBR Staff Writer
Eli Lilly and Company has acquired two investigational positron emission tomography (PET) tracers from Siemens Medical Solutions USA.
Inward Investment > News
Ares Life Sciences to acquire US firm Antigen Laboratories
By PBR Staff Writer
Ares Life Sciences, a Switzerland-based healthcare-focused investment group, has signed a definitive agreement to acquire the complete share capital of Planet Biopharmaceuticals.
Inward Investment > News
Water Street invests in pharmaceutical services company
By PBR Staff Writer
Private equity firm Water Street Healthcare Partners has invested in CCBR-SYNARC, to expand its global presence in the pharmaceutical services sector.
Inward Investment > News
Mobidiag, Genewave, Amplidiag merge to develop new diagnostic tests for infectious diseases
By PBR Staff Writer
Mobidiag, Genewave and Amplidiag have signed a definitive agreement to combine the three companies to set up a new company, which will offer integrated, high-multiplex diagnostic tests for infectious diseases.
Inward Investment > News
31-45 of 421 results